Myofolate

Myofolate is a nutraceutical supplement developed and distributed by Delfran Pharmaceuticals, a South African company specializing in female healthcare. The product is an oral supplement provided in sachet form, containing a combination of myo-inositol and folate (specifically as L-methyltetrahydrofolate or levomefolic acid). Myofolate is designed to address myo-inositol deficiency and support female reproductive health, particularly in the context of infertility and Polycystic Ovary Syndrome (PCOS). Myo-inositol acts as a precursor for second messengers involved in insulin and follicle-stimulating hormone (FSH) signaling, helping to restore metabolic and hormonal balance, improve oocyte quality, and support regular ovulation. The inclusion of bioactive folate supports DNA synthesis and reduces the risk of neural tube defects during early pregnancy. It is widely used in South Africa as a support for women undergoing IVF or seeking to improve general fertility.

Brand names

Myofolate

Other names

Myo-inositol + FolateMyo-inositol + L-methyltetrahydrofolateMyo-inositol + Levomefolic acid